Expression of Apoptosis Inhibitor Gene Survivin in Bladder Carcinoma and Its Clinical Implication

宋涛,李鸣,石怀银,洪宝发,那彦群
DOI: https://doi.org/10.3760/j:issn:1000-6702.2004.12.017
2004-01-01
Abstract:Objective To study the expression of survivin, an apoptosis inhibitor gene,in bladder carcinoma,and to investigate its clinical and pathological implications. Methods We detected the expression of survivin in 60 cases (48 men and 12 women) of bladder carcinoma and 10 cases of non-tumor bladder tissues (controls) by immunohistochemistry (SP) method.The mean age of the 60 cases at diagnosis was 59 years.The pathological grading showed Grade Ⅰ in 16 cases,Grade Ⅱ in 24 and Grade Ⅲ in 20.The clinical staging showed T 1 in 13 cases,T 2 in 15,T 3 in 21 and T 4 in 11.Of the 60 cases,21 developed relapse. Results The overall positive rate of survivin in 60 cases of bladder carcinoma was 60.0% (n=36).No survivin was found in 10 cases of non-tumor bladder tissues.The positive rate of survivin in Grade Ⅰ cases of bladder carcinoma was 37.5%(6/16),in Grade Ⅱ and Ⅲ cases of bladder carcinoma was 66.7%(16/24) and 70.0%(14/20);the difference of positive rates between Grade Ⅰ and Grade Ⅱ,Grade Ⅲ cases was significant (P0.01).The positive rates of survivin in T 1,T 2,T 3 and T 4 cases of bladder carcinoma were 53.8%(7/13),60.0%(9/15),61.9%(13/21) and 63.6%(7/11),respectively,which showed a trend of increasing,but there was no statistically significant difference among them (P0.05).The positive rate of survivin in cases of relapse was 80.9% (17/21). Conclusions Survivin may play an essential role in bladder carcinogenesis and serve as a marker for prognosis of bladder cancer.
What problem does this paper attempt to address?